VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DNTH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DNTHDianthus Therapeutics, Inc.
$83.98$3.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDNTHQuarterly Financials

Dianthus Therapeutics, Inc. (DNTH) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Dianthus Therapeutics, Inc. (DNTH) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

DNTH Income Statement

Quarterly statement

DNTH Income Statement

Dianthus Therapeutics, Inc. (DNTH) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue1.21M761K463K284K396K193K1.16M1.33M2.17M1.86M874K457K924K969K476K1.18M1.17M000
Revenue Growth %205.56%294.3%-60.19%-78.58%-81.77%-89.64%33.07%190.15%135.06%92.26%83.61%-61.11%-21.23%-------
Cost of Goods Sold0076K00000000019K84K049K01.2M1.21M535K
COGS % of Revenue--16.41%---------2.06%8.67%-4.17%----
Gross Profit1.21M761K387K284K396K193K1.16M1.33M2.17M1.86M874K457K905K885K476K1.13M1.17M-1.2M-1.21M-535K
Gross Margin %100%100%83.59%100%100%100%100%100%100%100%100%100%97.94%91.33%100%95.83%100%---
Gross Profit Growth %205.56%294.3%-66.72%-78.58%-81.77%-89.64%33.07%190.15%140%110.51%83.61%-59.41%-22.85%174%139.34%310.47%320.49%-149.69%--
Operating Expenses59.68M62.24M46.92M69.83M40.68M35.12M34.34M33.24M32.07M24.07M18.72M13.41M16.66M12.66M8.16M11.82M9.43M16.89M22.62M19.61M
OpEx % of Revenue4932.4%8179.11%10133.91%24586.27%10273.74%18196.89%2952.71%2506.94%1476.61%1291.84%2141.65%2935.01%1803.46%1306.6%1714.08%1005.87%803.67%---
Selling, General & Admin14.08M13.56M12.47M9.93M8.2M8.87M7.34M6.83M6.53M6M5.64M4.63M8.7M2.41M2.31M1.99M2.21M6.48M7.29M7.03M
SG&A % of Revenue1163.8%1781.47%2692.87%3496.48%2069.44%4595.34%630.87%515.01%300.55%321.9%645.31%1013.57%941.99%248.5%485.71%169.19%188.32%---
Research & Development45.6M48.69M34.53M59.9M32.49M26.25M27M26.41M25.54M18.07M13.08M8.78M7.96M10.25M5.85M9.83M7.22M10.41M15.34M12.58M
R&D % of Revenue3768.59%6397.63%7457.45%21089.79%8204.29%13601.55%2321.84%1991.93%1176.06%969.94%1496.34%1921.44%861.47%1058.1%1228.36%836.68%615.35%---
Other Operating Expenses00000000000000000000
Operating Income-58.47M-61.48M-46.53M-69.54M-40.29M-34.93M-33.18M-31.92M-29.9M-22.2M-17.84M-12.96M-15.76M-11.78M-7.68M-10.69M-8.25M-18.08M-23.83M-20.14M
Operating Margin %-4832.4%-8079.11%-10050.32%-24486.27%-10173.74%-18096.89%-2852.71%-2406.94%-1376.61%-1191.84%-2041.65%-2835.01%-1705.52%-1215.27%-1614.08%-910.04%-703.67%---
Operating Income Growth %-45.13%-76.03%-40.26%-117.89%-34.74%-57.3%-85.93%-146.34%-89.73%-88.55%-132.25%-21.16%-90.93%34.88%67.76%46.91%54.76%-2.69%-27.47%-5.64%
EBITDA-58.36M-61.38M-46.46M-69.44M-40.19M-34.83M-33.04M-31.84M-29.78M-22.09M-17.74M-12.85M-15.74M-11.69M-7.67M-10.64M-8.24M-16.89M-22.62M-19.61M
EBITDA Margin %-4823.39%-8065.05%-10033.91%-24452.11%-10148.74%-18045.6%-2841.27%-2401.06%-1371.27%-1185.88%-2029.4%-2812.47%-1703.46%-1206.6%-1611.13%-905.87%-702.81%---
EBITDA Growth %-45.22%-76.22%-40.59%-118.12%-34.93%-57.64%-86.3%-147.71%-89.22%-88.96%-131.28%-20.75%-90.93%30.76%66.1%45.71%53.46%1.42%-24.15%-5.57%
D&A (Non-Cash Add-back)109K107K76K97K99K99K133K78K116K111K107K103K19K84K14K49K10K1.2M1.21M535K
EBIT-46.64M-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-12.96M-14.76M-13.06M-7.68M-10.12M-8.25M-17.27M-22.95M-19.29M
Net Interest Income12.14M11.54M6.26M5.27M3.66M3.4M3.79M3.99M4.45M4.71M4.22M2.44M1.03M687K606K640K416K0884K0
Interest Income12.14M11.54M6.26M5.27M3.66M3.4M3.79M3.99M4.45M4.71M4.22M2.44M1.03M687K606K640K416K812K884K0
Interest Expense00000000000000000812K00
Other Income/Expense11.83M11.27M5.7M167.45M3.52M3.3M3.67M3.48M4.73M4.6M4.1M2.39M996K636K594K577K470K812K884K848K
Pretax Income-46.64M-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-10.56M-14.76M-11.14M-7.09M-10.12M-7.78M-17.27M-22.95M-19.29M
Pretax Margin %-3854.79%-6598.55%-8819.44%34473.59%-9284.09%-16388.08%-2537.49%-2144.8%-1159.02%-945.09%-1573%-2311.38%-1597.73%-1149.64%-1489.29%-860.94%-663.6%---
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-46.64M-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-10.56M-14.76M-11.14M-7.09M-10.12M-7.78M-17.27M-22.95M-19.29M
Net Margin %-3854.79%-6598.55%-8819.44%34473.59%-9284.09%-16388.08%-2537.49%-2144.8%-1159.02%-945.09%-1573%-2311.38%-1597.73%-1149.64%-1489.29%-860.94%-663.6%---
Net Income Growth %-26.87%-58.76%-38.37%444.25%-46.04%-79.64%-114.66%-169.24%-70.52%-58.05%-93.93%-4.42%-89.66%35.5%69.11%47.56%55.33%-2.03%-31.23%-6.19%
Net Income (Continuing)-46.64M-50.22M-40.83M97.91M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-10.56M-14.76M-11.14M-7.09M-10.12M-7.78M-17.27M-22.95M-19.29M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.81-0.90-0.852.59-0.97-0.88-0.82-0.81-0.74-0.51-0.54-2.33-3.78-0.87-7.70-2.67-2.10-4.70-6.25-5.25
EPS Growth %16.49%-2.27%-3.66%419.75%-31.08%-72.55%-51.85%65.24%80.42%41.38%92.99%12.73%-79.94%81.49%-23.3%49.15%55.88%6.81%-8.42%12.34%
EPS (Basic)-0.81-0.90-0.852.59-0.97-0.88-0.82-0.81-0.74-0.51-0.54-2.33-3.78-0.87-7.70-2.67-2.10-4.70-6.25-5.25
Diluted Shares Outstanding57.34M56.03M48.03M37.79M37.79M35.82M35.79M35.03M34.24M34.23M25.67M4.53M3.91M3.79M3.79M3.79M3.7M3.68M3.67M3.67M
Basic Shares Outstanding57.34M56.03M48.03M37.79M37.79M35.82M35.79M35.03M34.24M34.23M25.67M4.53M3.91M3.79M3.79M3.79M3.7M3.68M3.67M3.67M
Dividend Payout Ratio--------------------